Skip to main content

CRDL · Cardiol Therapeutics Inc. · Analyst Estimates

Track CRDL — free
$1.33 -0.08 (-5.68%) At close · Oct 5
Market Cap
$205.37M
Shares
121.51M
Volume · Oct 5 2.96M Avg daily vol (3M) 1.29M

Analyst Estimates

Compare analyst forecasts for Cardiol Therapeutics Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-10-05 23:18 UTC · Publication dates shown per estimate · 16 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
CAD
Publication date not stated
-0.33
-0.31733
-0.292
—
-0.325
-0.36
-0.314
-0.36
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
1
1
0
0
Revenue
CAD
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
CAD
Publication date not stated
-0.42
-0.32675
-0.22
—
-0.30333
-0.28
-0.33175
-0.28
— — — —
EPS
analysts
Publication date not stated
— — —
4
— — — —
0
0
1
1
Revenue
CAD
Publication date not stated
0
1666670
10000000
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
6
— — — — — — — —

Q ending 2026-09-30

Analyst estimates for Q ending 2026-09-30
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
CAD
Publication date not stated
-0.08
-0.07633
-0.069
—
-0.08
-0.10333
-0.07633
-0.10333
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
0
0
1
1
Revenue
CAD
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 30 days ago Average, 60 days ago Average, 7 days ago Average, 90 days ago Estimates lowered, last 30 days Estimates lowered, last 7 days Estimates raised, last 30 days Estimates raised, last 7 days
EPS
CAD
Publication date not stated
-0.09
-0.083
-0.069
—
-0.09
-0.10333
-0.083
-0.10333
— — — —
EPS
analysts
Publication date not stated
— — —
3
— — — —
2
2
1
1
Revenue
CAD
Publication date not stated
0
0
0
— — — — — — — — —
Revenue
analysts
Publication date not stated
— — —
4
— — — — — — — —
Key facts CIK 1702123 CUSIP 14161Y200 13F (30d) 1 filings 1 filers Visit website Investor relations